VCL and breast cancer: During breast cancer metastases, EZH2 was shown to be phosphorylated at T367 via p38 MAP kinase which induces cytosolic localization of EZH2 and further promotes EZH2 binding to many cytoskeletal regulators including vinculin which play critical role in cell migration and invasion.